Streetbeat News

Analyst Ratings

ENTG

Mizuho analyst Kieran De Brun maintains a Buy rating on Entegris (NASDAQ:ENTG) and raises the price target from $98 to $113.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:23 pm

ONEW

OneWater Marine (NASDAQ:ONEW) has received 5 analyst ratings in the last quarter, with 1 being bullish, 3 somewhat bullish, and 1 indifferent. The average 12-month price target for the company is $36.0, a decrease of 2.7% from the previous average of $37.00.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 3:23 pm

CDNS

Cadence Design Sys's (NYSE:CDNS) short percent of float has risen 8.82% since its last report, with 2.26 million shares sold short, which is 1.11% of all regular shares available for trading. It would take traders 1.57 days to cover their short positions on average. The company's short interest is less than its peer group average of 3.16%.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 3:23 pm

ALTR

Rosenblatt analyst Blair Abernethy maintains a 'Buy' rating on Altair Engineering (NASDAQ:ALTR) and raises the price target from $70 to $74.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:23 pm

EXPE

B of A Securities analyst Justin Post maintains a Buy rating on Expedia Group (NASDAQ:EXPE) but lowers the price target from $150 to $145.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:22 pm

NET

Mizuho analyst Gregg Moskowitz maintains a Neutral rating on Cloudflare (NYSE:NET) and raises the price target from $65 to $70.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:22 pm

TNDM

Tandem Diabetes Care reported mixed Q2 financial results, leading to a drop in its share price. Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $45 to $33.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 3:22 pm

CSCO

CVS

PXD

UBER

On CNBC's 'Halftime Report Final Trades', several stocks were discussed. Pioneer Natural Resources (PXD) reported a strong quarter, beating consensus estimates, and is expected to rise further. Cisco Systems (CSCO) was named as a final trade, despite a recent Underperform rating from Exane BNP Paribas. CVS Health (CVS) was highlighted as a defensive health care company, having reported better-than-expected Q2 results and issued FY23 guidance. Uber (UBER) was still favored despite reporting worse-than-expected Q2 revenue and issuing Q3 guidance.

Portfolio Pulse from Lisa Levin

August 04, 2023 | 3:22 pm

DLB

Rosenblatt analyst Steve Frankel maintains a 'Buy' rating on Dolby Laboratories (NYSE:DLB) and raises the price target from $93 to $98.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:22 pm

PROF

Raymond James analyst Rahul Sarugaser has downgraded Profound Medical (NASDAQ:PROF) from Strong Buy to Outperform.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:22 pm